Back to Search Results
Image Place holder

Jacques Fontaine, MD

★★★★★
★★★★★
4.9 (187 ratings)
Specialty: Thoracic Surgery
Sub Specialty: General Surgery
Program: Thoracic Oncology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Esophageal Cancer, Lung Cancer, Mesothelioma, Pancoast Tumor, Thymoma

Dr. Fontaine received his medical degree from McGill University in Montreal, Canada, and completed his general surgery residency at Boston University.  In 2006, he graduated as chief resident in thoracic surgery at Brigham and Women's Hospital – Harvard Medical School.  Dr. Fontaine began his thoracic surgery practice at University of Montreal but was then recruited to become part of the Department of Thoracic Surgery at Brown Medical School in Providence, RI.  He was in charge of developing a thoracic surgery program at one of Brown University's teaching hospitals. In 2011, Dr. Fontaine joined Moffitt Cancer Center in Tampa, FL – the 3rd largest cancer center in the United States.  He is a Senior Member of the Departments of Thoracic and GI Oncology as well as a Professor at the University of South Florida.  Dr. Fontaine has a keen interest in mesothelioma, lung and esophageal cancers. He is the Section Head of the Mesothelioma Research and Treatment Center.  He has developed an expertise in robotic surgery and is the Program Director for Moffitt’s Robotic Thoracic Fellowship Program.  He has mentored several thoracic surgeons around the country in learning his robotic surgery techniques.  Together with Dr. Eric Toloza, he has built a center of excellence in robotic surgery – one of the busiest in the country.


Education & Training

Fellowship:

  • Harvard Medical School, Brigham and Women’s Hospital - Thoracic Surgery

Residency:

  • University of Montreal - General Surgery PGY 1-2
  • Boston University - General Surgery PGY 2-5
  • University of Massachusetts - Cardiothoracic Surgery

Medical School:

  • McGill University - MD
Video Profile
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Ash-Rafzadeh H, Chambers TJ, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Surgical Day of Week on Postoperative Outcomes After Robotic-Assisted Pulmonary Lobectomy. Cureus. 2023 Feb.15(2):e35379. Pubmedid: 36846643. Pmcid: PMC9949999.
  • Pointer DT, McDonald JA, Naffouje SA, Mehta R, Fleming JB, Fontaine JP, Lauwers GY, Frakes JM, Hoffe SE, Pimiento JM. The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer. J Surg Oncol. 2022 Sep.126(3):465-478. Pubmedid: 35578777. Pmcid: PMC9339510.
  • Jermihov A, Chen L, Echavarria MF, Ng EP, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Socio-Economic Status on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy. Cureus. 2022 Jun.14(6):e26201. Pubmedid: 35754434. Pmcid: PMC9224841.
  • Pointer DT, Saeed S, Naffouje SA, Mehta R, Hoffe SE, Dineen SP, Fleming JB, Fontaine JP, Pimiento JM. Outcomes of 350 Robotic-assisted Esophagectomies at a High-volume Cancer Center: A Contemporary Propensity-score Matched Analysis. Ann Surg. 2022 Jul.276(1):111-118. Pubmedid: 33201093.
  • Robinson LA, Fontaine J, El-Haddad G, Bryant S, Perez B, Toloza E, Kis B. Novel Subdiaphragmatic Ligation of Left Thoracic Duct for Refractory Postoperative Left Chylothorax. Ann Thorac Surg. 2022 Jan.113(1):e29-e31. Pubmedid: 33794166.
  • Kulkarni S, Chen L, Jermihov A, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Distance of Residence From the Cancer Center Influences Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy?. Cureus. 2022 Aug.14(8):e28646. Pubmedid: 36158383. Pmcid: PMC9495283.
  • Wood AC, Zhang Y, Mo Q, Cen L, Fontaine J, Hoffe SE, Frakes J, Dineen SP, Pimiento JM, Walko CM, Mehta R. Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status. Oncologist. 2022 Apr.27(4):307-313. Pubmedid: 35380714. Pmcid: PMC8982441.
  • Jermihov A, Tsalatsanis A, Kulkarni S, Velez FO, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Lowest Postoperative Pre-albumin on Outcomes after Robotic-Assisted Pulmonary Lobectomy. JSLS. 2021 Jul.25(3). Pubmedid: 34483640. Pmcid: PMC8397293.
  • Parvathaneni S, Penafiel M, Garrett J, Toloza E, Fontaine J. Intrathoracic gastric volvulus complicating a robotic left upper lobectomy: A case report and review of literature. Int J Surg Case Rep. 2021 Jan.78:110-115. Pubmedid: 33333353. Pmcid: PMC7749293.
  • Saeed SM, Naffouje S, Mehta R, Hoffe SE, Fontaine JP, Lauwers GY, Shah P, Frakes J, Pimiento JM. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis. Dis Esophagus. 2021 Aug.34(8). Pubmedid: 32996568.
  • Song EY, Venkat P, Fradley M, Frakes JM, Klocksieben F, Fontaine J, Mehta R, Saeed S, Hoffe SE, Pimiento JM. Clinical factors associated with the development of postoperative atrial fibrillation in esophageal cancer patients receiving multimodality therapy before surgery. J Gastrointest Oncol. 2020 Feb.11(1):68-75. Pubmedid: 32175107. Pmcid: PMC7052762.
  • Rishi A, Zhang GG, Yuan Z, Sim AJ, Song EY, Moros EG, Tomaszewski MR, Latifi K, Pimiento JM, Fontaine JP, Mehta R, Harrison LB, Hoffe SE, Frakes JM. Pretreatment CT and 18 F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer. J Med Imaging Radiat Oncol. 2020 Dec.65(1):102-111. Pubmedid: 33258556.
  • Pimiento JM, Fontaine JP. Minimally invasive transthoracic esophagectomy: pushing the boundaries to improve surgical outcomes. J Thorac Dis. 2019 May.11(Suppl 9):S1336-S1338. Pubmedid: 31245126. Pmcid: PMC6560543.
  • Liu J, Nahrwold DA, Serdiuk AA, Koontz DB, Fontaine JP. Intraoperative Goal-Directed Anesthetic Management of the Patient with Severe Pulmonary Hypertension. Am J Case Rep. 2019 Jul.20:998-1001. Pubmedid: 31292431. Pmcid: PMC6640173.
  • Mumtaz H, Khalil F, Tandon A, Toloza E, Fontaine JP. Primary bronchial Ewing sarcoma. Int J Surg Case Rep. 2019 Jul.61:230-233. Pubmedid: 31377551. Pmcid: PMC6698311.
  • Deol PS, Sipko J, Kumar A, Tsalatsanis A, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of insurance type on perioperative outcomes after robotic-assisted pulmonary lobectomy for lung cancer. Surgery. 2019 Aug.166(2):211-217. Pubmedid: 31202473.
  • Saeed SM, Fontaine JP, Dam AN, Hoffe SE, Cameron M, Frakes J, Mehta R, Gurd E, Pimiento JM. Is Preoperative G-Tube Use Safe for Esophageal Cancer Patients?. J Am Coll Nutr. 2019 Aug.39(4):301-306. Pubmedid: 31397638.
  • Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F. Reply to Dickhoff et al. from authors of 'Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer'. Lung Cancer. 2018 Oct.124:322-323. Pubmedid: 30193907.
  • Veronesi G, Park B, Cerfolio R, Dylewski M, Toker A, Fontaine JP, Hanna WC, Morenghi E, Novellis P, Velez-Cubian FO, Amaral MH, Dieci E, Alloisio M, Toloza EM. Robotic resection of Stage III lung cancer: an international retrospective study. Eur J Cardiothorac Surg. 2018 Nov.54(5):912-919. Pubmedid: 29718155. Pmcid: PMC6454562.
  • Blackham AU, H Naqvi SM, Schell MJ, Jin W, Gangi A, Almhanna K, Fontaine JP, Hoffe SE, Frakes J, Venkat P, Pimiento JM. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer. J Surg Oncol. 2018 Feb.117(2):150-159. Pubmedid: 28833197. Pmcid: PMC7771345.
  • Baldonado JJAR, Amaral M, Garrett J, Moodie C, Robinson L, Keenan R, Toloza EM, Fontaine JP. Credentialing for robotic lobectomy: what is the learning curve? A retrospective analysis of 272 consecutive cases by a single surgeon. J Robot Surg. 2018 Dec.13(5):663-669. Pubmedid: 30560496.
  • Yang GQ, Mhaskar R, Rishi A, Naghavi AO, Frakes JM, Almhanna K, Fontaine J, Pimiento JM, Hoffe SE. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy. Dis Esophagus. 2018 Dec.32(8). Pubmedid: 30597022.
  • Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F. Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer. Lung Cancer. 2018 Aug.122:206-213. Pubmedid: 30032833.
  • Saeed NA, Mellon EA, Meredith KL, Hoffe SE, Shridhar R, Frakes J, Fontaine JP, Pimiento JM, Kothari N, Almhanna K. Adjuvant chemotherapy and outcomes in esophageal carcinoma. J Gastrointest Oncol. 2017 Oct.8(5):816-824. Pubmedid: 29184685. Pmcid: PMC5674263.
  • Murimwa GZ, Venkat PS, Jin W, Leuthold S, Latifi K, Almhanna K, Pimiento JM, Fontaine JP, Hoffe SE, Frakes JM. Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery. J Gastrointest Oncol. 2017 Oct.8(5):808-815. Pubmedid: 29184684. Pmcid: PMC5674260.
  • Kass KS, Velez-Cubian FO, Zhang WW, Toosi K, Tanvetyanon T, Rodriguez KL, Thau MR, Garrett JR, Moodie CC, Fontaine JP, Toloza EM. Effect of advanced age on peri-operative outcomes after robotic-assisted pulmonary lobectomy: Retrospective analysis of 287 consecutive cases. Geriatr Oncol. 2017 Mar.8(2):102-107. Pubmedid: 28041970.
  • Amaral M, Pimiento J, Fontaine JP. Robotic esophagectomy: the Moffitt Cancer Center experience. Ann Cardiothorac Surg. 2017 Mar.6(2):186-189. Pubmedid: 28447009. Pmcid: PMC5387147.
  • Venkat PS, Shridhar R, Naghavi AO, Hoffe SE, Almhanna K, Pimiento JM, Fontaine JP, Abuodeh Y, Meredith KL, Frakes JM. Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer. Dis Esophagus. 2017 Jul.30(7):1-9. Pubmedid: 30052899.
  • Luu C, Amaral M, Klapman J, Harris C, Almhanna K, Hoffe S, Frakes J, Pimiento JM, Fontaine JP. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?. World J Gastroenterol. 2017 Dec.23(46):8193-8199. Pubmedid: 29290655. Pmcid: PMC5739925.
  • Montané B, Toosi K, Velez-Cubian FO, Echavarria MF, Thau MR, Patel RA, Rodriguez K, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of Obesity on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy. Surg Innov. 2017 Apr.24(2):122-132. Pubmedid: 28128014.
  • Garcia-Henriquez N, Toloza EM, Khalil F, Echavarria MF, Garrett JR, Moodie CC, Kaszuba FJ, Fontaine JP. Extensive plastic bronchitis: etiology of a rare condition. J Thorac Dis. 2016 Sep.8(9):E961-E965. Pubmedid: 27747036. Pmcid: PMC5059329.
  • Velez-Cubian FO, Rodriguez KL, Thau MR, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Efficacy of lymph node dissection during robotic-assisted lobectomy for non-small cell lung cancer: retrospective review of 159 consecutive cases. J Thorac Dis. 2016 Sep.8(9):2454-2463. Pubmedid: 27746997. Pmcid: PMC5059267.
  • Nguyen DT, Fontaine JP, Robinson LA, Keenan RJ, Toloza EM. P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S195. Pubmedid: 27676508.
  • Nguyen DT, Fontaine JP, Robinson LA, Keenan RJ, Toloza EM. P1.17: Improved Survival for Stage-2 (N1) Pulmonary Adenocarcinoma and Squamous Cell Carcinoma After Pulmonary Lobectomy: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S191-S192. Pubmedid: 27676503.
  • Echavarria MF, Cheng A, Velez F, Ng E, Toloza E, Moodie C, Garrett J, Fontaine JP. P1.16: Comparison of Peri-Operative Outcomes After Robotic-Assisted Video-Thoracoscopic Lobectomies Versus Segmentectomies: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S190-S191. Pubmedid: 27676502.
  • Echavarria MF, Cheng A, Velez F, Ng E, Toloza E, Fontaine JP, Moodie C, Garrett J. P1.15: Comparison of Pulmonary Function After Robotic-Assisted Video-Thoracoscopic Lobectomies vs Segmentectomies: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct.11(10S):S189-S190. Pubmedid: 27676501.
  • Toosi K, Velez-Cubian FO, Glover J, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer. Surgery. 2016 Nov.160(5):1211-1218. Pubmedid: 27665362.
  • Velez-Cubian FO, Zhang WW, Rodriguez KL, Thau MR, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of small body habitus on peri-operative outcomes after robotic-assisted pulmonary lobectomy: retrospective analysis of 208 consecutive cases. J Thorac Dis. 2016 Jun.8(6):1245-1249. Pubmedid: 27293843. Pmcid: PMC4885994.
  • Robinson LA, Tanvetyanon T, Springett G, Fontaine J, Toloza E, Hodul P, Pimiento JM, Malafa M. Pulmonary metastasectomy for suspected pancreaticobiliary cancer. J Thorac Cardiovasc Surg. 2016 Jul.152(1):75-82. Pubmedid: 27050555.
  • Echavarria MF, Cheng AM, Velez-Cubian FO, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Robinson LA, Toloza EM. Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy. Am J Surg. 2016 Dec.212(6):1175-1182. Pubmedid: 27823756.
  • Glover JR, Velez-Cubian FO, Zhang WW, Toosi K, Tanvetyanon T, Ng EP, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy. J Thorac Dis. 2016 Dec.8(12):3614-3624. Pubmedid: 28149556. Pmcid: PMC5227215.
  • Glover J, Velez-Cubian FO, Toosi K, Ng E, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancer. J Thorac Dis. 2016 Aug.8(8):2165-2174. Pubmedid: 27621873. Pmcid: PMC4999683.
  • Ng EP, Velez-Cubian FO, Rodriguez KL, Thau MR, Moodie CC, Garrett JR, Fontaine JP, Toloza EM. Surgical outcomes associated with postoperative atrial fibrillation after robotic-assisted pulmonary lobectomy: retrospective review of 208 consecutive cases. J Thorac Dis. 2016 Aug.8(8):2079-2085. Pubmedid: 27621862. Pmcid: PMC4999667.
  • Blackham AU, Yue B, Almhanna K, Saeed N, Fontaine JP, Hoffe S, Shridhar R, Frakes J, Coppola D, Pimiento JM. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response. J Surg Oncol. 2015 Nov.112(6):597-602. Pubmedid: 26394724.
  • Dossett LA, Toloza EM, Fontaine J, Robinson LA, Reed D, Druta M, Letson DG, Zager JS, Gonzalez RJ. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma. J Surg Oncol. 2015 Jul.112(1):103-106. Pubmedid: 26179670.
  • Straughan DM, Azoury SC, Bennett RD, Pimiento JM, Fontaine JP, Toloza EM. Robotic-Assisted Esophageal Surgery. Cancer Control. 2015 Jul.22(3):335-339. Pubmedid: 26351890.
  • Straughan DM, Fontaine JP, Toloza EM. Robotic-Assisted Videothoracoscopic Mediastinal Surgery. Cancer Control. 2015 Jul.22(3):326-330. Pubmedid: 26351888.
  • Velez-Cubian FO, Ng EP, Fontaine JP, Toloza EM. Robotic-Assisted Videothoracoscopic Surgery of the Lung. Cancer Control. 2015 Jul.22(3):314-325. Pubmedid: 26351887.
  • Velez-Cubian F, Zhang WW, Rodriguez K, Thau M, Moodie C, Garrett J, Fontaine JP, Robinson L, Toloza E. Efficacy of Lymph Node Dissection During Robotic-Assisted Pulmonary Lobectomy for Non-small Cell Lung Cancer: Retrospective Analysis of 159 Consecutive Cases. Chest. 2014 Mar.145(3 Suppl):56A. Pubmedid: 24638719.
  • Rodriguez K, Velez-Cubian F, Zhang WW, Tanvetyanon T, Thau M, Moodie C, Garrett J, Fontaine JP, Robinson L, Toloza E. Effects of pulmonary function and of smoking history on perioperative outcomes after robotic-assisted pulmonary lobectomy: retrospective analysis of 201 consecutive patients. Chest. 2014 Mar.145(3 Suppl):48A. Pubmedid: 24638644.
  • Willson T, Sambo T, Fontaine JP, Connolly M, Podbielski F. Primary pulmonary T-cell lymphoma presenting as bilateral interstitial infiltrates. Chest. 2014 Mar.145(3 Suppl):315A. Pubmedid: 24638477.
  • Maguire K, Leung C, Kodali V, Taylor B, Fontaine JP, Rojas CA, Guglin M. Heart failure due to tension hydrothorax after left pneumonectomy. Heart Surg Forum. 2013 Dec.16(6):E319-E323. Pubmedid: 24370800.
  • Ahmed S, Fontaine JP, Ng T. Pancreatic herniation after transhiatal esophagectomy. Ann Thorac Surg. 2010 Jan.89(1):308-309. Pubmedid: 20103270.
  • Ng T, Birnbaum AE, Fontaine JP, Berz D, Safran HP, Dipetrillo TA. Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung cancer. Ann Surg Oncol. 2010 Feb.17(2):476-482. Pubmedid: 19915918.
  • Paul S, Raja S, Su S, Fontaine JP, Zellos L, Sugarbaker DJ. Unusual case of hemoptysis 13 years after bilobectomy. Ann Thorac Surg. 2007 Mar.83(3):1188-1190. Pubmedid: 17307493.
  • Podbielski FJ, Rodriguez HE, Zhu RY, Worley TA, Fontaine JP, Connolly MM. Aortoesophageal fistula secondary to reflux esophagitis. Dig Surg. 2007.24(1):66-67. Pubmedid: 17369684.
  • Fontaine JP, Issa RA, Yantiss RK, Podbielski FJ. Intrathoracic gallstones: a case report and literature review. JSLS. 2006 Jul-Sep.10(3):375-378. Pubmedid: 17212899. Pmcid: PMC3015711.
  • Hedeshian MH, Wang X, Xu B, Fontaine JP, Podbielski FJ. Subcutaneous metastasis from esophageal cancer. Asian Cardiovasc Thorac Ann. 2006 Dec.14(6):520-521. Pubmedid: 17130332.
  • Podbielski FJ, Issa RA, Fontaine JP, Rodriguez HE. Thoracoscopic transillumination in chest wall resection. Asian Cardiovasc Thorac Ann. 2004 Jun.12(2):171-172. Pubmedid: 15213089.
  • Issa RA, Podbielski FJ, Fontaine JP, Connolly AE, Walsh WV, Fraire AE. Esophagectomy in a patient with AIDS. Dis Esophagus. 2004.17(3):270-272. Pubmedid: 15361104.

Patient Comments
Overall Satisfaction
4.9
★★★★★
★★★★★

187 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments